BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?
BioNTech SE (NASDAQ:BNTX) is ending a mid-stage study of its personalized mRNA cancer vaccine, autogene cevumeran, after an…
Browsing Tag
BNTX
1 post